ArticleMicrobial biotechnology2026
A Scaffoldomics Platform for Modular In Vivo Enzyme Colocalisation and Its Application to Naringenin Biosynthesis.
Article in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modular plug-and-play engineering of Klebsiella phages with dual receptor-binding proteins for efficient host range design.Journal of biological engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Insufficient product yield remains a major bottleneck in the development of microbial cell factories for fine chemical production. In vivo enzyme colocalisation on synthetic scaffolds has emerged as a promising strategy to enhance metabolic efficiency, yet current approaches are often labour-intensive and inefficient. Here, we present the development of a 'scaffoldomics' platform, a generic synthetic framework designed to enable combinatorial scaffolding of biosynthetic pathways for the generation of diverse multi-enzyme complexes. This system enables the assembly of up to four pathway enzymes onto a protein scaffold. As a proof of concept, the platform was applied to the biosynthesis of naringenin, a key flavonoid intermediate. Integration of a chromosomally encoded naringenin biosensor in Escherichia coli allowed for real-time detection and pathway evaluation. The biosensor response curve was established and confirmed functional naringenin production. Moreover, comparative experiments demonstrated that the addition of a scaffold to docking enzymes significantly enhanced yield up to a ~19-fold, indicating a positive colocalisation effect. These results highlight the utility of the scaffoldomics platform as a powerful tool for further efficient combinatorial design, construction, and optimisation of biosynthetic pathways in synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.